Palavra-chave: CHRONIC MYELOID LEUKAEMIA

ANGIOGENESIS INHIBITOR SARS-COV-2 BCR-ABL NILOTINIB DASATINIB GSTT1 THETA1 CML GENERIC IMATINIB CYTOGENETIC RESPONSES GENE RUNX1 TYROSINE KINASE INHIBITORS EXON 6 IMATINIB GSTM1 POLYMORPHISMS RESPONSE TO SECOND-LINE HOCT1 VACCINES S-TRANSFERASE MU1 BCR-ABL1 SECOND-GENERATION PERIPHERAL-BLOOD D-HPLC PHILADELPHIA CHROMOSOME-POSITIVE